Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00476970 · ClinicalTrials.gov registry record · NA
Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,223
- Enrollment target
NCT00476970: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00476970 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,223 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00476970, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,223 participants
- Enrollment target
Study Summary
The goal of this study is to implement and in a controlled randomised trial test a program to identify and overcome barriers to CRC screening and thus improve CRC screening rates at MGH Chelsea HC. Our hypothesis is that a bilingual navigator program, enhanced by using trained interpreting staff will improve CRC screening rates at MGH Chelsea HC overall, and decrease disparities between patients with limited English proficiency and English speakers
Interventions
- BEHAVIORAL Patient Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,223 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-09 |
| Phase | NA |
What the finished NCT00476970 record still lists
NCT00476970 is an interventional study that assigns participants to a tested intervention. Its 1,223 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 1 intervention - of which Patient Navigation is the first listed.
NCT00476970 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00476970 about?
NCT00476970 is a clinical study titled "Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations". The goal of this study is to implement and in a controlled randomised trial test a program to identify and overcome barriers to CRC screening and thus improve CRC screening rates at MGH Chelsea HC. Our hypothesis is that a bilingual navigator program, enhanced by using trained interpreting staff wi...
What is the current status of trial NCT00476970?
This trial is currently completed. It is a NA study. The enrollment target is 1,223 participants. The study started on 2007-09. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00476970?
The interventions under investigation include: Patient Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00476970?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00476970's enrollment target sits among peer trials
1,223 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- NCT06143956 · 1,217 participants · Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia